Central Drug Agency Seeks Clarification From Glenmark On Its COVID Drug

The Drugs Controller General of India (DCGI) has asked for a clarification from Glenmark Pharmaceuticals regarding its alleged "false claims" on the utilisation of anti-viral FabiFlu (favipiravir) on...

from NDTV News - Special https://ift.tt/3jjsiDu
https://ift.tt/eA8V8J

Comments

Popular posts from this blog

Cash reaches 40% of 20 cr women beneficiaries